ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
September 02 2020 - 9:00AM
Business Wire
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that
it will participate at the following upcoming virtual investor
conferences:
Citi 15th Annual BioPharma Virtual Conference Date:
Wednesday, September 9, 2020 Panel: Emerging Therapies for
Psychiatric Disorders at 1:30 p.m. Eastern Time
Morgan Stanley 18th Annual Global Healthcare Conference
Date: Monday, September 14, 2020 Fireside chat presentation: 3:45
p.m. Eastern Time
Cantor Virtual Global Healthcare Conference Date:
Wednesday, September 16, 2020 Fireside chat presentation: 11:20
a.m. Eastern Time
These conferences will all be held virtually. Live webcasts of
the panel and presentations will be accessible on the company’s
website, www.acadia-pharm.com, under the investors section and an
archived recording will be available on the website for
approximately one month following each presentation.
About ACADIA Pharmaceuticals ACADIA is a biopharmaceutical
company focused on the development and commercialization of
innovative medicines to address unmet medical needs in central
nervous system disorders. ACADIA has developed and commercialized
the first and only medicine approved for the treatment of
hallucinations and delusions associated with Parkinson’s disease
psychosis. ACADIA’s development efforts are focused on pimavanserin
for additional neuropsychiatric conditions, trofinetide for Rett
syndrome, ACP-044 for pain management and an early-stage muscarinic
receptor program. This press release and further information about
ACADIA can be found at: www.acadia-pharm.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200902005382/en/
Media Contact: ACADIA Pharmaceuticals Inc. Eric Endicott (858)
914-7161 media@acadia-pharm.com
Investor Contact: ACADIA Pharmaceuticals Inc. Mark Johnson, CFA
(858) 261-2771 ir@acadia-pharm.com
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Sep 2023 to Sep 2024